Nowadays, research has shown that hepatocellular carcinoma and high-risk medulloblastoma exhibit aberrant overexpression of HDAC5, while colon cancer [55] and lung cancer patients’ poor prognosis are linked to HDAC5 downregulation [56]. This evidence concerns the gene HDAC5 and lung carcinoma.